Interparfums header image

Interparfums

ITP

Equity

ISIN FR0004024222 / Valor 86977

Euronext - Euronext Paris (2026-06-05)
EUR 25.42+1.03%

Interparfums
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Interparfums is a global beauty company that develops, manufactures, markets and distributes fragrance and related personal-care products under its own names and through long-term licensing agreements with fashion and luxury brands. The business focuses on fine fragrances and companion body products, handling product development, packaging and global logistics while managing brand partnerships and retail relationships; its products are sold through department stores, specialty retailers, duty-free/travel retail and online channels across the Americas, Europe and Asia. Publicly traded, Interparfums operates as a bridge between brand owners and global retail networks, generating revenue primarily from sales of licensed and proprietary fragrance lines.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (18.05.2026):

Inter Parfums, Inc. reported its 2023 fourth-quarter and record full-year results. The company states it delivered its 2023 target EPS, announced a 20% increase in its cash dividend, and affirmed its guidance for 2024.

Quarter & Full‑Year Results

Inter Parfums reports that fourth-quarter 2023 and the full year 2023 were record results for the company (company-provided release did not include line-item financials in the text provided).

EPS

The company says it "delivered 2023 target EPS" (no specific EPS figure was provided in the supplied report text).

Cash Dividend

Inter Parfums announced a 20% increase in its cash dividend for 2023.

2024 Guidance

The company affirmed its guidance for 2024 (the supplied report did not include numerical guidance details).

Prior-Year Note

The supplied report also references Inter Parfums' prior announcement that 2022 fourth quarter and full year were record results and that 2023 guidance and a 25% dividend increase had been raised at that time.

Summarized from source with an LLMView Source

Key figures

-32.5%1Y
-55.7%3Y
-45.1%5Y

Performance

31.5%1Y
31.6%3Y
32.5%5Y

Volatility

Market cap

2484 M

Market cap (USD)

Daily traded volume (Shares)

121,487

Daily traded volume (Shares)

1 day high/low

40.45 / 39.85

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%CHF 324.60
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 20.07
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.09%CHF 83.30
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.77%CHF 4.45
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%USD 43.38
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.47%CHF 137.80
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%USD 20.14
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.00
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-13.51%CHF 1.60
Ambu A/S
Ambu A/S Ambu A/S Valor: 39639588
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.21%DKK 66.00